In vitro benchmarking of NF-κB inhibitors-Reference-Cited by-同舟云学术

In vitro benchmarking of NF-κB inhibitors

Published:2020-04 Issue: Volume:873 Page:172981
ISSN:0014-2999
Container-title:European Journal of Pharmacology
language:en
Short-container-title:European Journal of Pharmacology

Author:

Harrold Alexandria P.,Cleary Megan M.,Bharathy Narendra,Lathara Melvin,Berlow Noah E.,Foreman Nicholas K.,Donson Andrew M.,Amani Vladimir,Zuercher William J.,Keller Charles

Funder

National Institutes of Health

Publisher

Elsevier BV

Subject

Pharmacology

Reference43 articles.

1. Piceatannol inhibits TNF-induced NF-kappaB activation and NF-kappaB-mediated gene expression through suppression of IkappaBalpha kinase and p65 phosphorylation;Ashikawa;J. Immunol.,2002

2. Activation of DNA-binding activity in an apparently cytoplasmic precursor of the NF-κB transcription factor;Baeuerle;Cell,1988

3. I-B kinase-2 inhibitor blocks inflammation in human airway smooth muscle and a rat model of asthma;Birrell;Am. J. Respir. Crit. Care Med.,2005

4. A2Aadenosine receptor upregulation correlates with disease activity in patients with systemic lupus erythematosus;Bortoluzzi;Arthritis Res. Ther.,2016

5. Control of I kappa B-alpha proteolysis by site-specific, signal-induced phosphorylation;Brown;Sci,1995

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Pharmacological properties and underlying mechanisms of aurantio‑obtusin (Review);Experimental and Therapeutic Medicine;2023-06-26

2. Heat-clearing and blood-cooling decoction alleviates psoriasis by suppressing proliferation and inflammatory response of keratinocytes via EZH2/NF-κB;European Journal of Integrative Medicine;2022-10

3. epi-Aszonalenin B from Aspergillus novofumigatus inhibits NF-κB activity induced by ZFTA-RELA fusion protein that drives ependymoma;Biochemical and Biophysical Research Communications;2022-03

4. Effects of NF-kB Signaling Inhibitors on Bed Bug Resistance to Orally Provisioned Entomopathogenic Bacteria;Insects;2021-03-30

5. Hydroxyazoles as acid isosteres and their drug design applications—Part 1: Monocyclic systems;Advances in Heterocyclic Chemistry;2021